Bicara Therapeutics

Senior Manager, Accounting and SEC Reporting

Boston, Remote. Posted 3 months ago

The role

This person will prepare all SEC reporting documents including Form 10K and 10Q. They will also manage G&A accruals, perform stock compensation activities, and support Sarbanes-Oxley Act compliance.

What you will do

  • Leads the preparation of Form 10-Q quarterly reports, Form 10-K annual reports, financial sections of earning press releases and other current reports.
  • Manages external SEC financial reporting and filing process.
  • Monitors the development and applicability of emerging accounting and reporting rules.
  • Partner with the Controller and the Senior Director of Accounting on the review and assessment of complex accounting matters and new accounting standards.
  • Lead accounting for stock-based compensation for compliance with ASC 718.
  • Prepare and post monthly journal entries and prepare monthly account reconciliation.
  • Collaborate with other G&A teams including legal, IR and others.
  • Develop and maintain accounting policies and procedures.
  • Identify opportunities to streamline and automate controls and reporting processes.

Required qualifications

  • BS/MS in Accounting
  • 8 plus years of relevant experience
  • Solid understanding of US GAAP
  • Ability to manage multiple priorities
  • Ability to research and interpret accounting guidance and draft accounting memos
  • Proven subject matter knowledge
  • Attention to detail
  • Ability to communicate effectively with the team
  • Strong interpersonal skills
  • Effectiveness in working collaboratively with cross functional team members and with external partners
  • Strong team player
  • Proficient knowledge of Excel, Word, PowerPoint

Nice to have

  • Active CPA license
  • Prior experience working with Workiva or similar SEC reporting platform
  • Experience working with NetSuite, Prendio and Bill.com

About the company

Bicara Therapeutics is a clinical-stage biotech company pioneering bifunctional antibodies for targeted tumor modulation. Founded in 2020, the company has a global team of over 100 employees headquartered in Boston.